Literature DB >> 3162734

The binding of factor Va to phospholipid vesicles.

S Krishnaswamy1, K G Mann.   

Abstract

The analysis of free sulfhydryl groups in factor Va using dithiobis-(nitrobenzoic acid) (DTNB) indicated the presence of one accessible thiol in each of the two subunits of the cofactor. Intact factor Va contained one readily accessible sulfhydryl group under native conditions and approximately two such groups after denaturation. A comparison of the rate of modification of the accessible thiol in factor Va under native conditions to those observed with the isolated subunits indicated that the thiol present in component D of the cofactor was readily accessible to reaction with DTNB. Factor Va was reacted with the sulfhydryl-directed fluorophore N-(1-pyrene)maleimide, resulting in the concomitant loss of the accessible thiol with no detectable alteration in the activity of the cofactor. This fluorescent derivative of factor Va (Pyr-Va) was used to examine the binding of factor Va to phospholipid vesicles by fluorescence polarization. Fluorescence polarization of the pyrene moiety increased saturably when Pyr-Va was titrated with increasing concentrations of vesicles composed of phosphatidylcholine and phosphatidylserine (PS). Systematic analysis of the binding of Pyr-Va to PCPS (75% phosphatidylcholine, 25% PS) indicated that the binding interaction was characterized by a dissociation constant of 2.7 x 10(-9) M with 42 mol of PCPS bound per mol of Va at saturation. The data obtained by varying the PS content of the vesicles are consistent with the interpretation that the Va-combining site on the vesicle surface is composed of a discrete number of PS molecules. The binding of Pyr-Va to PCPS was independent of added calcium ion and could be reversed by the addition of unlabeled Va or isolated component E but not by component D. Analysis of the displacement curves indicated that native factor Va or isolated component E and Pyr-Va mutually excluded each other on the vesicle surface with identical affinities. Competition experiments conducted using component E digested by factor Xa or the isolated derivative peptides indicated that the cleavage of component E by factor Xa had no effect on the PCPS binding properties of this subunit. Further, the data obtained with the isolated peptides suggest that the lipid-binding domain of component E is present in the amino-terminal region of this subunit.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162734

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma.

Authors:  Coen Maas; Joost C M Meijers; J Arnoud Marquart; Kamran Bakhtiari; Cees Weeterings; Philip G de Groot; Rolf T Urbanus
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

3.  New insights into the spatiotemporal localization of prothrombinase in vivo.

Authors:  Lacramioara Ivanciu; Sriram Krishnaswamy; Rodney M Camire
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

4.  Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.

Authors:  M Arai; D Scandella; L W Hoyer
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation.

Authors:  Jack D Stopa; Donna Neuberg; Maneka Puligandla; Bruce Furie; Robert Flaumenhaft; Jeffrey I Zwicker
Journal:  JCI Insight       Date:  2017-01-12

6.  Roles of factor Va heavy and light chains in protein and lipid rearrangements associated with the formation of a bovine factor Va-membrane complex.

Authors:  V Koppaka; W F Talbot; X Zhai; B R Lentz
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

7.  Insights into the complex association of bovine factor Va with acidic-lipid-containing synthetic membranes.

Authors:  G A Cutsforth; V Koppaka; S Krishnaswamy; J R Wu; K G Mann; B R Lentz
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

8.  Binding of bovine factor Va to phosphatidylcholine membranes.

Authors:  V Koppaka; B R Lentz
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

9.  Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.

Authors:  T L Ortel; M A Quinn-Allen; L A Charles; D Devore-Carter; W H Kane
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

10.  Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association.

Authors:  Abed R Zeibdawi; Jean E Grundy; Bogna Lasia; Edward L G Pryzdial
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.